On November 14, 2014, Lipocine Inc. announced that it has terminated the employment of Dr. Srinivasan Venkateshwaran, Chief Technology Officer and Vice President Research & Development, and Gerald Simmons, Corporate Business Development Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.49 USD | +16.01% |
|
+26.20% | +240.14% |
Jun. 10 | Lipocine Inc. Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late-Breaking Session at EASL Congress 2024 | CI |
May. 09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.14% | 50.75M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- Lipocine Inc. Announces Board Resignations